These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33185874)
1. Experimental Methods for the Immunological Characterization of Paradoxical Psoriasis Reactions Induced by TNF-α Biologics. Morelli M; Scarponi C; Madonna S; Albanesi C Methods Mol Biol; 2021; 2248():155-165. PubMed ID: 33185874 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development. Fania L; Morelli M; Scarponi C; Mercurio L; Scopelliti F; Cattani C; Scaglione GL; Tonanzi T; Pilla MA; Pagnanelli G; Mazzanti C; Girolomoni G; Cavani A; Madonna S; Albanesi C J Pathol Clin Res; 2020 Jan; 6(1):55-68. PubMed ID: 31577850 [TBL] [Abstract][Full Text] [Related]
3. Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors. Morelli M; Carbone ML; Scaglione GL; Scarponi C; Di Francesco V; Pallotta S; De Galitiis F; Rahimi S; Madonna S; Failla CM; Albanesi C Front Immunol; 2024; 15():1346687. PubMed ID: 38495872 [TBL] [Abstract][Full Text] [Related]
4. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease. Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544 [TBL] [Abstract][Full Text] [Related]
5. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464 [TBL] [Abstract][Full Text] [Related]
6. Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction? Lu J; Lu Y J Transl Autoimmun; 2023 Dec; 7():100211. PubMed ID: 37731549 [TBL] [Abstract][Full Text] [Related]
7. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages. Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755 [TBL] [Abstract][Full Text] [Related]
16. Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents. Navarro R; Delgado-Jiménez Y; Guinea-Viniegra J; Llamas-Velasco M; Daudén E J Cutan Pathol; 2022 Feb; 49(2):116-122. PubMed ID: 34322902 [TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. Nestle FO; Conrad C; Tun-Kyi A; Homey B; Gombert M; Boyman O; Burg G; Liu YJ; Gilliet M J Exp Med; 2005 Jul; 202(1):135-43. PubMed ID: 15998792 [TBL] [Abstract][Full Text] [Related]
18. The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. Gschwandtner M; Mommert S; Köther B; Werfel T; Gutzmer R J Invest Dermatol; 2011 Aug; 131(8):1668-76. PubMed ID: 21614010 [TBL] [Abstract][Full Text] [Related]
19. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis. Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906 [TBL] [Abstract][Full Text] [Related]
20. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease. George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]